Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant-Reference-Cited by-同舟云学术

Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant

Published:2015-08 Issue:4 Volume:19 Page:198-202
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Strehl Johanna D.,Wachter David L.,Fiedler Jutta,Heimerl Engelbert,Beckmann Matthias W.,Hartmann Arndt,Agaimy Abbas

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference30 articles.

1. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer—mechanisms and potential therapeutic insights;Wang;Clin Cancer Res,2014

2. The spectrum of SWI/SNF mutations, ubiquitous in human cancers;Shain;PLoS One,2013

3. Chromatin modifiers and tumor suppression;Klochendler-Yeivin;Biochim Biophys Acta,2001

4. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology;Judkins;Adv Anat Pathol,2007

5. INI1-deficient tumors: diagnostic features and molecular genetics;Hollmann;Am J Surg Pathol,2011

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer;Gynecologic Oncology;2024-09

2. High-Grade Endometrial Carcinoma;Gynecologic and Obstetric Pathology;2024

3. Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features;Cancers;2023-10-26

4. NUT carcinoma and thoracic SMARCA4‐deficient undifferentiated tumour: facts and controversies;Histopathology;2023-10-24

5. Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma;Gynecologic Oncology;2023-09